[
  {
    "ts": null,
    "headline": "ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025",
    "summary": "SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:https://investor.resmed.com•",
    "url": "https://finnhub.io/api/news?id=40f61efcabd26f6ec3eefb97a2a9064bd69cef6019a6be1b428b01be8fd69606",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736456700,
      "headline": "ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025",
      "id": 132353747,
      "image": "https://s.yimg.com/ny/api/res/1.2/CuD6_dv2CPHDMg..ds9g9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NTQ-/https://media.zenfs.com/en/globenewswire.com/0661be2b39b4f1faec9bff065e033c25",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:https://investor.resmed.com•",
      "url": "https://finnhub.io/api/news?id=40f61efcabd26f6ec3eefb97a2a9064bd69cef6019a6be1b428b01be8fd69606"
    }
  },
  {
    "ts": null,
    "headline": "3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW",
    "summary": "Chipotle Mexican Grill, Ulta Beauty and ServiceNow are currently exhibiting superb earnings growth.",
    "url": "https://finnhub.io/api/news?id=656fceef0b9d105ecf39f36f3e1769fb32a069a993da10d623322ac50e91cda7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736453100,
      "headline": "3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOW",
      "id": 132353748,
      "image": "https://media.zenfs.com/en/zacks.com/641b12f376ef2f209641d595529bcc7f",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Chipotle Mexican Grill, Ulta Beauty and ServiceNow are currently exhibiting superb earnings growth.",
      "url": "https://finnhub.io/api/news?id=656fceef0b9d105ecf39f36f3e1769fb32a069a993da10d623322ac50e91cda7"
    }
  },
  {
    "ts": null,
    "headline": "Expanding Global Network, Vaccine Sales Support PAHC Stock",
    "summary": "Phibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing vaccine technologies.",
    "url": "https://finnhub.io/api/news?id=04a29302a869a7d31083c4719eaca95862e4cbc4a6c21d66f0630e96178b2d84",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736440020,
      "headline": "Expanding Global Network, Vaccine Sales Support PAHC Stock",
      "id": 132353749,
      "image": "https://media.zenfs.com/en/zacks.com/2ca3419ae750add78735b19bbc8a540b",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Phibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing vaccine technologies.",
      "url": "https://finnhub.io/api/news?id=04a29302a869a7d31083c4719eaca95862e4cbc4a6c21d66f0630e96178b2d84"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Add Glaukos Stock to Your Portfolio Now",
    "summary": "GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.",
    "url": "https://finnhub.io/api/news?id=73562e8b76723f1fd1de05f0429b806a5cbd13b6c39c68f38e938942fa134f0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736426580,
      "headline": "Here's Why You Should Add Glaukos Stock to Your Portfolio Now",
      "id": 132347382,
      "image": "https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.",
      "url": "https://finnhub.io/api/news?id=73562e8b76723f1fd1de05f0429b806a5cbd13b6c39c68f38e938942fa134f0b"
    }
  },
  {
    "ts": null,
    "headline": "BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement",
    "summary": "Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.",
    "url": "https://finnhub.io/api/news?id=337c4730cbe5d2219464fe44487773523752863aa9393c8f2dd1e4a5eb5f249f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736426580,
      "headline": "BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement",
      "id": 132347875,
      "image": "https://media.zenfs.com/en/zacks.com/98f062077b0e287fed47c16e0521fc3d",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.",
      "url": "https://finnhub.io/api/news?id=337c4730cbe5d2219464fe44487773523752863aa9393c8f2dd1e4a5eb5f249f"
    }
  }
]